The company’s founder, Dr Lissette Torres-Cabrera, pioneered the technology after having experienced complications during the pregnancy of her first child three years ago. She informs, “The most amazing aspect of our Corrective Enhancement Imagery Program (CEIP) is that the mother doesn’t require a special scan, any regular 3/4D scan is all that’s needed. The system is able to re-engineer existing imagery to create an ultra-clear image, allowing you ‘for the first time’ to see your unborn baby from within the womb with remarkable detail. It’s the closest thing to seeing your baby before birth.”
 |
 |
| Before and after Sense My Baby(TM) using CEIP-Corrective Enhancement Imagery Program. | |
Using ‘structural’ information from the original image, data characteristics are analysed and the system is able to differentiate between the degraded image area and that of a higher resolution – the latter being the area that is isolated and then captured. These images are then individually enhanced using CEIP, before being re-engineered to create a layering effect—where required the orientation of the image is changed to facilitate the reconstruction.
Leading industry experts are already showing an interest in the technology. Professor Kypros Nicolaides, the world’s leading authority on Obstetrics and director of the Harris Birthright Research Centre for Fetal Medicine at King’s College Hospital, was the first to privately review the pioneering work and confirm that the imagery was the most advanced one he has ever seen stating, “The images are absolutely stunning and the detail is truly amazing”.
The new technology provides a game-changing advancement in ultrasound image recognition and is poised to provide parents with a unique opportunity to see their baby’s face like never before.
“We are rapidly changing the way that expectant parents see their children for the first time. This is a pivotal moment in the life of any parent and we’re delighted to be leading the industry in making it as memorable a moment as possible,” Torres-Cabrera concludes.
The technology is due to become commercially available within weeks.
EH News Bureau
